| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/27/2006 | US20060165685 Bispecific anti-erb-b antibodies and their use in tumor therapy |
| 07/27/2006 | US20060165684 T-cell immune response cDNA 7 (TIRC7) antagonist; rheumatoid arthritis; comprising all three complementarity determining regions (CDRs) of the VH and all three complementarity determining regions (CDRs) of the VL variable regions; inhibiting proliferation of peripheral blood mononuclear cells |
| 07/27/2006 | US20060165683 Methods and compositions for control of bone formation via modulation of sympathetic tone |
| 07/27/2006 | US20060165682 Humanized antibodies that recognize beta amyloid peptide |
| 07/27/2006 | US20060165681 Antibodies to myelin associated glycoprotein (MAG); neurological diseases/disorders |
| 07/27/2006 | US20060165680 Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors |
| 07/27/2006 | US20060165678 Measuring changes in level of antigen recognizable by a monoclonal antibody or antigen binding fragment; monoclonal antibody is produced by hybridoma cell line; decreased level indicates a reduced tumor; diagnosis, cell purification |
| 07/27/2006 | US20060165677 recombinant dimer consisting of two IgE-dependent histamine releasing factor (HRF), known as translationally controlled tumor protein(TCTP); for treatment of allergic diseases including asthma and rhinitis or malaria |
| 07/27/2006 | US20060165676 Identification of tsh receptor autoantibodies using affinity-purified antibodies |
| 07/27/2006 | US20060165675 Modulation of mesenchymal cells via iga-receptors |
| 07/27/2006 | US20060165653 Use of Fc receptor polymorphisms as diagnostics for treatment strategies for immune-response disorders |
| 07/27/2006 | US20060165592 Nk cell receptor conjugates for treating malignancies |
| 07/27/2006 | DE102005002353A1 Use of receptor multimerization epitope (RME) of advanced glycation end product receptor (AGER) as immunogen, useful for preparing antibodies for diagnosis and treatment of e.g. spinal injuries or diabetic complications |
| 07/27/2006 | CA2595800A1 Specific binding members for ngf |
| 07/27/2006 | CA2593561A1 Combining therapies targeting multiple toll-like receptors and use thereof |
| 07/27/2006 | CA2592177A1 Fixed dosing of her antibodies |
| 07/27/2006 | CA2591914A1 Fc-fusion constructs binding to phosphatidylserine and their therapeutic use |
| 07/26/2006 | EP1683865A2 Mammalian proteins and in particular CD200 |
| 07/26/2006 | EP1683864A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/26/2006 | EP1683811A2 Compositions and methods for the treatment of tumors |
| 07/26/2006 | EP1683810A1 Method for producing antibodies |
| 07/26/2006 | EP1683809A1 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 07/26/2006 | EP1682890A2 Screening assays and methods of tumor treatment |
| 07/26/2006 | EP1682866A2 Gel-shell beads with adsorbed or bound biomolecules |
| 07/26/2006 | EP1682665A2 Use of fibroblast growth factor fragments |
| 07/26/2006 | EP1682584A1 A pharmaceutical composition comprising an immunoglobulin fc region as a carrier |
| 07/26/2006 | EP1682583A1 Protein complex using immunoglobulin fragment and method for the preparation thereof |
| 07/26/2006 | EP1682582A1 Method for the mass production of immunoglobulin constant region |
| 07/26/2006 | EP1682581A1 Igg fc fragment for a drug carrier and method for the preparation thereof |
| 07/26/2006 | EP1682580A2 Human monoclonal antibody having fat-reducing effect |
| 07/26/2006 | EP1682579A1 Laminin-5 gamma2-binding peptides, related compositions, and use thereof |
| 07/26/2006 | EP1682578A1 Peptide-based immunization therapy for treatment of atherosclerosis |
| 07/26/2006 | EP1682576A1 Variants of human glycoprotein hormone alpha chain: compositions and uses thereof |
| 07/26/2006 | EP1682575A1 Igf-i responsive gene and use thereof |
| 07/26/2006 | EP1682180A2 Antagonist anti-cd40 monoclonal antibodies and methods for their use |
| 07/26/2006 | EP1682179A2 Enhanced b cell cytotoxicity of cdim binding antibody |
| 07/26/2006 | EP1682178A2 Methods of therapy for cancers expressing the cd40 antigen |
| 07/26/2006 | EP1682177A2 Use of antagonist anti-cd40 antibodies for treatment of chronic lymphocytic leukemia |
| 07/26/2006 | EP1682170A2 Compositions able to prevent neurodegenerative processes and methods of assaying the same |
| 07/26/2006 | EP1682164A2 Cytokine antagonist molecules |
| 07/26/2006 | EP1682163A1 Proteins involved in quorum sensing |
| 07/26/2006 | EP1682106A2 Modified fviii having reduced immunogenicity through mutagenesis of a2 and c2 epitopes |
| 07/26/2006 | EP1465921B1 Corticotropin releasing factor receptor 2 agonists |
| 07/26/2006 | EP1390543B1 New polynucleotides and polypeptides of the ifnalpha-17 gene |
| 07/26/2006 | EP1311297B1 A method for reducing stress-induced overproduction of neuropeptide y in an individual |
| 07/26/2006 | EP1263784B1 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 07/26/2006 | EP1257297B1 Compositions and methods for treatemnt of angiogenesis in pathological lesions |
| 07/26/2006 | EP1240313B1 Homologue enzymes of human heparanase and splice variants thereof |
| 07/26/2006 | EP1163519B1 Protein isolation and analysis |
| 07/26/2006 | EP1161522B1 Method of isolating cd8+ cells, and related hybridoma cells, antibodies and polypeptides |
| 07/26/2006 | EP1125130B1 Detection of acid-resistant micro-organisms in a stool |
| 07/26/2006 | EP1075517B1 Chimeric receptors |
| 07/26/2006 | EP1068301B1 Bacterial transglutaminases |
| 07/26/2006 | EP0856058B1 Cell-cycle checkpoint genes |
| 07/26/2006 | EP0832222B1 Linc-53 from c. elegans and its uses in listing compounds involved in the control of cell behaviour and pharmaceutical compositions |
| 07/26/2006 | CN1809592A Recombinant antibodies and fragments recognising ganglioside N-glycolyl-GM3 and use thereof in the diagnosis and treatment of tumours |
| 07/26/2006 | CN1809591A Human monoclonal antibodies against bacillus anthracis protective antigen |
| 07/26/2006 | CN1809589A GITR ligand and GITR ligand-related molecules and antibodies and uses thereof |
| 07/26/2006 | CN1809382A A method for the prevention of malaria infection of humans by hepatocyte growth factor antagonists |
| 07/26/2006 | CN1809374A Proton-sensing G-protein coupled receptors and DNA sequences thereof |
| 07/26/2006 | CN1807625A Immune magnetic bead negtive-sieve method for sorting cow X sperm based on H-Y antigen |
| 07/26/2006 | CN1807601A Immune colloid gold test paper strip for detecting sulfadiazine residue and its preparation method |
| 07/26/2006 | CN1807596A Preparation method of polyclonal antibody of cellular karyoplasms transferring acceptor protein 13 |
| 07/26/2006 | CN1807455A Breast cancer related gene DREE, its coded protein and uses |
| 07/26/2006 | CN1807454A GIBC gene and its coded protein and uses |
| 07/26/2006 | CN1807451A ZIBC gene and its coded protein and uses |
| 07/26/2006 | CN1807450A SIP gene and its coded protein and uses |
| 07/26/2006 | CN1266163C Cotton verticillium wilt germ secreted exciton gene and its application |
| 07/26/2006 | CN1265840C Immunity coupler of containing monoclonal antibody Fab' segment of anti TV type collagenase poly glutamic acid-blemycin A5 |
| 07/25/2006 | US7081523 And stimulate erythropoiesis; teatment of anemia |
| 07/25/2006 | US7081522 Gene causative of Rothmund-Thomson syndrome and gene product |
| 07/25/2006 | US7081521 Anti-PRO788 antibodies |
| 07/25/2006 | US7081520 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
| 07/25/2006 | US7081519 Antibodies to serine protease polypeptides |
| 07/25/2006 | US7081518 For the diagnosis and therapy of cancers of the ovary, stomach, squamous cells, mesotheliomas and other malignant cells expressing mesothelin |
| 07/25/2006 | US7081517 Nucleotide sequences coding for use in detection of mamary gland cancer |
| 07/25/2006 | US7081514 Genetic engineering; culture product; recovering |
| 07/25/2006 | US7081513 Peptides having Chemotaxis Inhibitory Protein from Staphylococcus aureus (CHIPS) activity for diagnosis, prophylaxis and treatment of inflammation and HIV |
| 07/25/2006 | US7081354 Interleukin and albumin fusion protein |
| 07/25/2006 | CA2206423C Antithrombotic agent and anti-von willebrand factor monoclonal antibodies |
| 07/25/2006 | CA2156935C Methods of detecting collagen degradation in vivo |
| 07/20/2006 | WO2006076640A1 Monoclonal antibodies that bind or neutralize hepatitis b virus |
| 07/20/2006 | WO2006076584A2 Kid31 and antibodies that bind thereto |
| 07/20/2006 | WO2006075784A1 ANTI-α9 INTEGRIN ANTIBODY AND THE USE THEREOF |
| 07/20/2006 | WO2006075668A1 STABILIZED HUMAN IgG1 AND IgG3 ANTIBODIES |
| 07/20/2006 | WO2006075142A2 FORMS OF FACTOR XIIa |
| 07/20/2006 | WO2006074914A2 Human rna helicase and therapeutic uses thereof |
| 07/20/2006 | WO2006074547A1 Nitrogen-regulated sugar sensing gene and protein and modulation thereof |
| 07/20/2006 | WO2006060419A9 Biomarkers for pre-selection of patients for anti-igf1r therapy |
| 07/20/2006 | WO2006052900A3 Targeted innate immunity |
| 07/20/2006 | WO2006045750A3 T-cell stimulatory peptides from the melanoma-associated chondroitin sulfate proteoglycan and their use |
| 07/20/2006 | WO2006039173A3 Uses of an endothelial cell receptor |
| 07/20/2006 | WO2006036291A3 Antibodies directed against amyloid-beta peptide and methods using same |
| 07/20/2006 | WO2006032472A3 Immunogenic composition for use in vaccination against staphylococcei |
| 07/20/2006 | WO2006014726A3 Immunoglobulins comprising predominantly a man5glcnac2 glycoform |
| 07/20/2006 | WO2006001965A3 Reducing the risk of human anti-human antibodies through v gene manipulation |
| 07/20/2006 | WO2005115121A3 Adenylyl cyclase antibodies, compositions and uses thereof |
| 07/20/2006 | WO2005070126A3 Methods and compositions for treating human diseases and wounds with ucp and fas inhibitors |
| 07/20/2006 | WO2005062929A3 Use of fc receptor polymorphisms as diagnostics for treatment strategies for immune-response disorders |
| 07/20/2006 | WO2005016955A3 Nogo receptor antagonists |